Concepedia

Gavin Choy

GC

14

Publications

788

Citations

12

H-Index

1997

Active since

Affiliations

Astex Pharmaceuticals(Current)

Roswell Park Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

Duke Medical Center

Princess Margaret Cancer Centre

Gavin Choy is an author at Astex Pharmaceuticals specializing in medicine, pharmacology, and immunology.

Top concepts

MedicinePharmacologyOncologyImmunologyCancer TherapyHepatitisHepatologyHepatitis BCancer ResearchPharmacotherapy

Publications per year

1997–2018

14

Publications

14

Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre- and Post-Liver Transplantation Patients

Eugene R. Schiff, Ching‐Lung Lai, Stefanos J. Hadziyannis et al. · Hepatology · 2003 · 365 citations

Transplantation Medicine, Hepatitis B, Immunology +21

The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer

Fang Fang, Joanne M. Munck, Jessica Tang et al. · Clinical Cancer Research · 2014 · 96 citations · Full text

SGI-110. DNA methyltransferase inhibitor, Oncolytic

Elizabeth A. Griffiths, Gavin Choy, Sanjeev Redkar et al. · Drugs of the Future · 2013 · 70 citations · Full text

Tumor Biology, Oncology, Global Hypomethylation +15

The Benefits of In‐Home Pharmacy Evaluation for Older Persons

Elaine Hsia Der, Laurence Z. Rubenstein, Gavin Choy · Journal of the American Geriatrics Society · 1997 · 51 citations

First Clinical Results Of a Randomized Phase 2 Study Of SGI-110, a Novel Subcutaneous (SQ) Hypomethylating Agent (HMA), In Adult Patients With Acute Myeloid Leukemia (AML)

Hagop M. Kantarjian, Elias Jabbour, Karen Yee et al. · Blood · 2013 · 33 citations

Rows per page

1–5 of 14